nach oben

International Journal of Diabetes in Developing Countries

Erschienen in:

01.12.2014 | Original Article

A study on prevalence of abnormal glucose tolerance and correlation of insulin resistance with dyslipidemia in South-Indian women with polycystic ovary syndrome

verfasst von: N. Rajendra Prasad, Aparna R. Bitla, M. M. Suchitra, G. Raja Gopal, Alok Sachan, P. V. L. N. Srinivasa Rao

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Abnormal glucose tolerance, insulin resistance, obesity and dyslipidemia are all potent cardiovascular risk factors that cluster in women with polycystic ovary syndrome (PCOS). Metabolic abnormalities in PCOS women cannot be explained by presence of obesity alone. The aim of this study is to analyze the prevalence of abnormal glucose tolerance and correlation of insulin resistance with serum lipid profile in South-Indian women with PCOS. In this prospective case control study, a total of 45 PCOS women were recruited. All patients underwent oral glucose tolerance test (OGTT) with blood samples at 0 and 2nd hour. Fasting insulin and lipid profiles were also measured in each case. The prevalence of impaired glucose tolerance (IGT), impaired fasting glycemia (IFG), type 2 diabetes mellitus and normal glucose tolerance was found to be 24.44 % (11/45), 4.44 % (2/45), 2.22 % (1/45) and 68.9 % (31/45) respectively. PCOS women had significantly higher serum total cholesterol (P = 0.002), triglycerides (P < 0.001), LDL-C (P = 0.001), VLDLC (P < 0.001) and decreased HDL-C (P < 0.001) compared to control group. No significant correlation was found between HOMA-IR with total cholesterol, triglycerides and LDL-C. However, HDL-C showed negative correlation with HOMA-IR (P = 0.04). Indian women with PCOS are at increased risk of IGT and NIDDM. Also, PCOS women have significant alteration in lipid profile and hence are more prone for cardiovascular disease.

Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in anunselected population. J Clin Endocrinol Metab. 2004;89:2745–9.PubMedCrossRef

Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998;83:2694–8.PubMed

Dokras A, Bochner M, Hollinrake E, Markham S, Vanvoorhis B, Jagasia DH. Screening women with polycystic ovarian syndrome for metabolic syndrome. Obstet Gynecol. 2005;106:131–7.PubMedCrossRef

Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE. Glucose intolerance in polycystic ovary syndrome–a position statement of the Androgen Excess Society. J Clin Endocrinol Metab. 2007;92:4546–56.PubMedCrossRef

Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16:347–63.PubMedCrossRef

Apridonizide T, Essah PA, Iuorno M, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:1929–35.CrossRef

Norman RJ, Mahabeer S, Masters S. Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. Fertil Steril. 1995;63:58–62.PubMed

Dunaif A, Givens JR, Haseltime FP, Merriam GR. Polycystic ovary syndrome: current issues in endocrinology and metabolism. Boston: Blackwell Scientific Publications; 1992. p. 377–84.

American Diabetic Association. Standards of medical care in diabetes – 2007. Diabetes care 2007;30 (suppl1), S4–S441. 10.

10.

Warnick GR, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem. 1990;36:15–9.PubMed

11.

Boyns DR, Crossley JM, Abrams ME. Oral glucose tolerance and related factors in a normal population sample. Br Med J. 1969;i:595–8.CrossRef

12.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.PubMedCrossRef

13.

Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434–8.PubMed

14.

Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 1980;50:113–6.PubMedCrossRef

15.

Chang RJ, Nakamura RM, Judd HL, Kaplan SA. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1983;57:356–9.PubMedCrossRef

16.

Ehrmann DA, Barnes RB, Rosenfield RL, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999;22:141–6.PubMedCrossRef

17.

Centres for Disease Control and Prevention (CDC). Prevalence of diabetes and impaired fasting glucose in adults in United States, 1999-2000. MMWR Morb Mortal Wkly Rep. 2003;52:833–7.

18.

Bhattacharya SM. Correlation between fasting glucose: insulin ratio, serum triglycerides level, and triglyceride: high density lipoprotein- cholesterol ratio in adolescent girls with polycystic ovarian syndrome. J Obstet Gynecol India. 2005;55:254–6.

19.

Anuradha K, Sreekumari N, Lavanya R. Association of obesity and Insulin resistance with dyslipidemia in Indian women with polycystic ovary syndrome. Ind J Med Sci. 2006;60:447–53.CrossRef

20.

Chen X, Yang D, Li L, Feng S, Wang L. Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome. Hum Reprod. 2006;21:2027–32.PubMedCrossRef

21.

Palmer MR, Gordon CM, Kartasher AI, Legro RS, Emans SJ, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:1017–23.CrossRef

22.

Weerakiet S, Srisombut C, Bunnag P, Sangtong S, Chuangsoongnoen N, Rojanasakul A. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2001;75:177–84.PubMedCrossRef

23.

Lee H, Oh JY, Sung YA, Chung H, Cho WY. The prevalence and risk factors for glucose in young Korean women with polycystic ovary syndrome. Endocrine. 2009;36:326–32.PubMedCrossRef

24.

Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S population aged 20-74yr. Diabetes. 1987;36:523–34.PubMedCrossRef

25.

Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84:165–9.PubMed

26.

Dunaif A, Finegood DT. β-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1996;81:942–7.PubMed

27.

Amowitz LL, Sobel BE. Cardiovascular consequences of polycystic ovary syndrome. Endocrinol Metab Clin N Am. 1999;28:439–58.CrossRef

28.

Joan CL, Seth LF, Yang J, Pressman AR, Selby JV, Alan SG. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:1357–63.CrossRef

29.

Vryonidou A, Papatheodorou A, Tavridou A, Terzi T, Loi V. Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:2740–6.PubMedCrossRef

30.

Olivier V, Regine P, Steegers-Theunissen M, Huberdina P, Smedts M, Geesje M. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case–control study. J Clin Endocrinol Metab. 2008;93:470–6.CrossRef

31.

Lithell H, Nillius SJ, Bergh T. Metabolic profile in obese women with the polycystic ovary syndrome. Int J Obs. 1987;11:1.

32.

Senoz S, Ozaksit G, Turhan NO. Lipid profiles in women with hirsuitism and polycystic ovaries. Gynecol Endocrinol. 1994;8:33.PubMedCrossRef

33.

Elbers JM, Giltay EJ, Teerlink T, Scheffer PG, Asscheman H, Seidell JC, et al. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf). 2003;58:562–71.CrossRef

34.

Sundararaman PG, Mamomahi R, Sridhar GR, Sridhar V, Sundaravalli A, Umachander M. Risk of atherosclerosis in women with polycystic ovary syndrome: a study from South India. Metab Syndr Relat Disord. 2003;1:271–5.PubMedCrossRef

Titel: A study on prevalence of abnormal glucose tolerance and correlation of insulin resistance with dyslipidemia in South-Indian women with polycystic ovary syndrome
verfasst von: N. Rajendra Prasad
Aparna R. Bitla
M. M. Suchitra
G. Raja Gopal
Alok Sachan
P. V. L. N. Srinivasa Rao
Publikationsdatum: 01.12.2014
Verlag: Springer India
Erschienen in: International Journal of Diabetes in Developing Countries / Ausgabe 4/2014
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-013-0188-1

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

Status of zinc and magnesium levels in type 2 diabetes mellitus and its relationship with glycemic status

Endogenous insulin secretion ability in meal tolerance test correlated with body mass index (BMI) in Japanese type 2 diabetes patients

Acromegaly presenting as Diabetic ketoacidosis

Ethical considerations of Ramadan fasting in diabetic patients according to Shiite school of thought

Saxagliptin as initial therapy in treatment-naive Indian adults with type 2 diabetes mellitus inadequately controlled with diet and exercise alone: a randomized, double-blind, placebo-controlled, phase IIIb clinical study

Knowledge and awareness of diabetes amongst diabetes patients in Wardha region